Chinook’s Edge School Division and the Central Alberta Collegiate Institute (CACI) are excited to announce the opening of a new CACI space in the Olds College Metals Building. Both parties were on ...

Diabetes during pregnancy is associated with an increased risk of neuro-developmental disorders (NDDs) like autism, according to a meta-analysis published in The Lancet Diabetes and Endocrinology.

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Few companies have closed as many acquisitions as CACI International. CACI has three acquisitions on our 2024 M&A Roundup: Azure Technologies, Applied Insight and Quandrint. Those moves brought ...

Can People With Diabetes Have Artificial Sweeteners? Yes, they can. Artificial sweeteners are just as sweet — and sometimes, up to 700 times sweeter — than regular sugar, but they have no ...

There's little research on how these additives impact health, but one new study has indicated consuming certain clusters is linked to an increase in type 2 diabetes. The research, published Tuesday in ...

Summary: Children born to mothers with diabetes face significantly higher risks of developing neurodevelopmental disorders, according to a sweeping new meta-analysis involving over 56 million ...

Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing ...

Of these, 110 studies looked at gestational diabetes – which develops during pregnancy and usually goes away after birth – and 80 looked at pre-gestational diabetes, when a woman has a type 1 ...

CACI has gotten torched over the last six months - since October 2024, its stock price has dropped 23.8% to $390.23 per share. This may have investors wondering how to approach the situation ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA ...